Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance

Journal of Autoimmunity

Volumn 27, Issue 2, 2006, Pages 125-133

  Gupta, Bhawna ^a   Raghav, Sunil Kumar ^a   Agrawal, Charu ^a   Chaturvedi, Ved Prakash ^b   Das, Rakha Hari ^a   Das, Hasi Rani ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ARMY HOSPITAL   (India)

Author keywords

Autoantibodies; Mannose binding lectin; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTHROPATHY; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DNA POLYMORPHISM; ENZYME IMMUNOASSAY; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; MALE; MANNOSE-BINDING LECTIN; PREVALENCE; RHEUMATOID FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

EID: 33749520432     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.07.002     Document Type: Article

References (28)

1. Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35 (2003) 341-348
2. Agrawal C., Raghav S.K., Gupta B., Das R.H., Chaturvedi V.P., Goswami K., et al. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch Med Res 36 (2005) 555-559
3. Gupta B., Agrawal C., Raghav S.K., Das S.K., Das R.H., Chaturvedi V.P., et al. Association of mannose binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples. J Hum Genet 50 (2005) 583-591
4. Nell V.P., Machold K.P., Stamm T.A., Eberl G., Heinzl H., Uffmann M., et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64 (2005) 1731-1736
5. Vencovsky J., Machacek S., Sedova L., Kafkova J., Gatterova J., Pesakova V., et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62 (2003) 427-430
6. Bond A., Alavi A., Axford J.S., Youinou P., and Hay F.C. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immunol 105 (1996) 99-103
7. Ohta M., Okada M., Yamashina I., and Kawasaki T. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J Biol Chem 265 (1990) 1980-1984
8. Presanis J.S., Kojima M., and Sim R.B. Biochemistry and genetics of mannan-binding lectin (MBL2). Biochem Soci Trans 31 (2003) 748-752
9. Eisen D.P., and Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37 (2003) 1496-1505
10. Kilpatrick D.C. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 1572 (2002) 401-413
11. Turner M.W., and Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease association. Rev Immunugenet 2 (2000) 305-322
12. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., and Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1 (1995) 237-243
13. Lipscombe R.J., Sumiya M., Hill A.V., Lau Y.L., Levinsky R.J., Summerfield J.A., et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1 (1992) 709-715
14. Tsutsumi A., Sasaki K., Wakamiya N., Ichikawa K., Atsumi T., Ohtani K., et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun 2 (2001) 99-104
15. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155 (1995) 3013-3020
16. Seelen M.A., Trouw L.A., van der Hoorn J.W., Fallaux-van den Houten F.C., Huizinga T.W., Daha M.R., et al. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin Exp Immunol 134 (2003) 335-343
17. Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., et al. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin Exp Immunol 136 (2004) 585-590
18. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (2004) 315-324
19. Prevoo M.L., van 't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
20. Petersen S.V., Thiel S., Jensen L., Steffensen R., and Jensenius J.C.J. An assay for the mannan-binding lectin pathway of complement activation. Immunol Methods 257 (2001) 107-116
21. Teitsson I., Withrington R.H., Seifert M.H., and Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 43 (1984) 673-678
22. Bruns D.E., Huth E.J., Magid E., and Young D.S. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 46 (2000) 893-895
23. Mok M.Y., Jack D.L., Lau C.S., Fong D.Y., Turner M.W., Isenberg D.A., et al. Antibodies to mannose binding lectin in patients with systemic lupus erythematosus. Lupus 13 (2004) 522-528
24. Stanworth S.J., Donn R.P., Hassall A., Dawes P., Ollier W., and Snowden N. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br J Rheumatol 37 (1998) 186-188
25. Horiuchi T., Tsukamoto H., Morita C., Sawabe T., Harashima S., Nakashima H., et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 1 (2000) 464-466
26. Larsen F., Madsen H.O., Sim R.B., Koch C., and Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 279 (2004) 21302-21311
27. Thiel S., Holmskov U., Hviid L., Laursen S.B., and Jensenius J.C. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 90 (1992) 31-35
28. Kravitz M.S., Pitashny M., and Shoenfeld Y. Protective molecules C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein a1 (Apo a1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol 25 (2005) 582-591